| Website | epizyme.com |
| Category | BioTech |
| Employees | |
| Founded | 2007 |
| Description | Blood Cancer and Tumor Treatments |
| Series B, 10/09 Bay City Capital Amgen Ventures Astellas Venture Management MPM Capital Kleiner Perkins Caufield & Byers | $32M |
Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors.
Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.
